NEW DELHI: There is adequate stock of drugs in the country for around 95% of ‘People Living with HIV’ (PLHIV) who are on first and second line of antiretroviral (ARV) regimens in the country, as per official sources.
The mainstay of treatment for more than 85% people living with HIV (PLHIV) is Tablet TLD, a fixed-dose-combination of three anti-retroviral drugs - Tenofovir (300mg) +Lamivudine (300mg) + Dolutegravir (50mg) - for which there is sufficient stock nationally to last more than three months, they said.
Tablet Dolutegravir-50mg is required for around 50,000 PLHIV who are either on alternate-1st/2nd or 3rd-line regimens or those with TB co-infection.
People with HIV have been protesting outside offices of the National AIDS Control Organisation (NACO) for days now, demanding that they receive medicines in a timely manner following shortages for nearly five months.